Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Delhi High Court on Wednesday asked Drug Controller General of India (DCGI) to consult experts and relevant stakeholders ...

WHO Director-General Dr Tedros Adhanom Ghebreyesus said the taxes could help countries 'adjust to the new reality' and ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...